Baseline bone health status in multi-ethnic South African postmenopausal breast cancer patients at initiation of aromatase inhibitor therapy: A descriptive study

INTRODUCTION: Osteoporosis (OP) risk factor assessment and bone mineral density (BMD) testing are frequently omitted at baseline in aromatase inhibitor (AI) studies, which may lead to misinterpretation of AI associated bone loss. The present study describes bone health of South African postmenopausa...

Descripción completa

Detalles Bibliográficos
Autores principales: Baatjes, Karin J., Kotze, Maritha J., McCaul, Micheal, Conradie, Magda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445512/
https://www.ncbi.nlm.nih.gov/pubmed/30939140
http://dx.doi.org/10.1371/journal.pone.0214153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445512/
https://www.ncbi.nlm.nih.gov/pubmed/30939140
http://dx.doi.org/10.1371/journal.pone.0214153

Ejemplares similares